GI Innovation, Inc. (KOSDAQ:358570)
6,810.00
+80.00 (1.19%)
Nov 2, 2026, 3:30 PM KST
GI Innovation Market Cap
GI Innovation has a market cap or net worth of 439.35 billion as of October 30, 2026. It is the 17,437th most valuable company in the world and the 489th biggest in South Korea. Its market cap has decreased by 54.30% in one year.
Market Cap
439.35B
Enterprise Value
402.04B
Revenue
5.50B
Global Rank
Country Rank
#489 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 30, 2023, GI Innovation's market cap has decreased from 445.59B to 439.35B, a decrease of -1.40%. That is a compound annual growth rate of -0.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 439.35B | -60.99% |
| Dec 30, 2025 | 1.13T | 187.90% |
| Dec 30, 2024 | 391.21B | -26.45% |
| Dec 28, 2023 | 531.89B | 19.37% |
| Mar 30, 2023 | 445.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Komipharm International | 651.95B |
| Chabiotech | 624.39B |
| Proteina | 599.21B |
| Pharmicell | 564.04B |
| Onconic Therapeutics | 549.89B |
| Hyundai Bioscience | 518.22B |
| GC Corp. | 415.33B |
| Medy-Tox | 412.68B |